Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

CRISPR Therapeutics is a leading biotech company, currently developing gene-editing techniques to cure hereditary diseases with promising projects underway. The company's Q1 2023 revenue was 100M USD ...

Like many overenthusiastic shoppers, I often go absolutely hog wild at the farmers market, only to find my vegetables have shriveled and rotted in my refrigerator. I try my best, but I just can’t cook ...

In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its ...

Ten years after its discovery, the implications of Crispr genome editing are profound and far-reaching, and we are only getting started. This tool, adapted from a bacterial immune system, allows us to ...

Labroots invites you to the 8th Annual CRISPR Virtual Event Series 2025, taking place on October 22nd, 2025! This event will explore the expanding frontier of CRISPR technology, with sessions covering ...

Labroots invites you to the 7th Annual Event in the CRISPR Virtual Event Series 2024 taking place on October 23rd, 2024! This event will continue the conversation of the abilities of CRISPR-based ...